News

The FDA decision follows the announcement in July by the European Medicines Agency (EMA) 1 which recommended the lifting of temporary restrictions in elderly people after the conclusion of a thorough ...
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...
Some good news, some ‘sobering,’ this month for tricuspid valve interventions, physician payments, and colchicine.
The Department of Health and Human Services (HHS) has announced a plan to end mRNA vaccine work funded by the Biomedical ...
A fter just a few controversial months, Vinay Prasad, MD, MPH, has stepped down as director of FDA's Center for Biologics Evaluation and Research (CBER).
On June 25, the FDA released a report announcing updated requirements in mRNA COVID-19 vaccine warning labels for Comirnaty by Pfizer Inc. and Spikevax by ModernaTX Inc. Prescribing information ...
The pill manufactured by Pfizer-typically taken three times a day-was approved on the NHS in the early 1990s to treat nerve pain and epilepsy.
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million. Leo Pharma announced it is paying Boehringer Ingelheim $105 million up front ...
Scientists have discovered that Pfizer's COVID-19 vaccine may increase the risk of eye damage, leading to vision loss.The new study specifically examined how ...
Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...